Global network platform for a physician, Doceree has announced the completion of $11 million in series A round funding led by Eight Roads Ventures in participation from F-Prime Capital and Alkemi Growth Capital.
“Doceree will use the funds to scale its global operations, expand partnerships, augment its product portfolio and advance the platform’s measurement and behavior lift capabilities to bring greater transparency to results. The funding will also help it embolden healthcare professional (HCP) communications for pharma and life sciences brands, agencies, and health information technology platforms,” the statement said.
Speaking on the fundraise, Harshit Jain, M.D., Founder & Global CEO, Doceree said, “It is critical for industry players like pharma companies and HCP-only platforms to understand and react to the digital touchpoints and behaviors of HCPs for delivering messages they resonate with. Our identity resolution technology and tailored products for different markets that adhere to the country-specific regulations and guidelines make it easy for pharma brands to engage with HCPs on digital mediums while enabling publishers to improve engagement on their platforms with relevant medical information from pharmaceutical and life sciences brands.”
Founded in 2019 by Harshit, a former physician who transitioned into the healthcare marketing space, Doceree offers pharma brands and media agencies solutions that seamlessly reach HCPs on professional HCP networks and within their digital workflow to achieve better patient health outcomes.
The company has refined HCP communications through its programmatic messaging capabilities to help marketers with more efficient, effective, and transparent messaging campaigns.
Commenting on the funding in Doceree, Ashish Venkataramani, Partner, Eight Roads Ventures said, “Doceree is transforming the way digital interactions between pharmaceutical brands and prescribers are facilitated. Pharma marketers navigate significant complexity across point-of-care systems and health information systems. Doceree’s technology platform seeks to disrupt the fragmented value chain for digital messaging to physicians, and will be at the forefront of this promising sector.”
“For pharma companies and publishers, having access to data-driven, actionable insights to strategize and implement communication initiatives is critical to reaching HCPs. Doceree has proven the ability to efficiently connect stakeholders and is well-positioned to serve the needs of the pharma industry,” Rahul Gupta, Board Member, Doceree added.
Further speaking on the investment round, Carl Byers, Partner, F-Prime Capital said, “Doceree has identified a largely overlooked white space in digital pharma marketing and is delivering innovative solutions to address some of the most critical challenges that pharma companies face today. We were drawn to the company’s vision and are looking forward to our partnership and continued support as they evolve into their next stage of growth.”